SNDX250516C20000
- 0.00
- 0.000.00%
Syndax Pharmaceuticals Newsroom
Barclays Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $19
J.P. Morgan Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Raises Target Price to $41
Syndax Pharmaceuticals Analyst Ratings
TD Cowen Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating
Syndax Pharmaceuticals Price Target Raised to $39.00/Share From $35.00 by JP Morgan
Syndax Pharmaceuticals Is Maintained at Buy by Citigroup
BTIG Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $43
Scotiabank Maintains Syndax Pharmaceuticals(SNDX.US) With Hold Rating, Maintains Target Price $16
Goldman Sachs Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $31
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $16 to $51
Syndax Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $51 Price Target
Analysts Are Bullish on Top Healthcare Stocks: Artelo Biosciences (ARTL), Syndax Pharmaceuticals (SNDX)
Promising Outlook for Syndax Pharmaceuticals: Buy Rating Supported by Revuforj Launch and Strategic Positioning
Barclays Reaffirms Their Buy Rating on Syndax Pharmaceuticals (SNDX)
Barclays Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $33
BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $25
Analysts Are Bullish on These Healthcare Stocks: Syndax Pharmaceuticals (SNDX), GE Healthcare Technologies Inc (GEHC)
Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $42
BTIG Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $43